Kalshi lobbying spend doubles as federal venue fight continues

Kalshi filed papers in federal court opposing New York's attempt to remand its prediction market case to state court, while simultaneously expanding its registered lobbying presence in Washington — two moves in the same week that, taken together, say something about how the company reads its own position.

The venue question matters more than it might appear. Kalshi's preemption argument — that the Commodity Exchange Act displaces state authority to regulate CFTC-designated contract markets — is structurally stronger in federal court. A federal judge applying Supremacy Clause analysis operates within a doctrinal tradition that has generally read congressional intent broadly when a federal regulatory scheme is comprehensive and explicit. State court judges are not unqualified to apply federal preemption doctrine, but remand creates procedural risk: a state tribunal may construe ambiguities in the CEA narrowly, and the appellate path back to federal review is longer and less certain.

New York's argument for remand, as reported, is that the underlying conduct implicates state gambling law — that whatever federal label attaches to these contracts, they land on New York's regulatory territory. That argument has more purchase than Kalshi's public posture acknowledges. The company obtained CFTC designation as a derivatives clearing organization, and its contracts are formally treated as swaps under Dodd-Frank architecture. But designation is not immunity. The preemption cases that have gone Kalshi's way have turned on whether the federal scheme occupies the field, not merely whether the specific instrument is federally authorized. New York will argue the field is not fully occupied. That argument has not yet met a definitive answer at the circuit level.

The lobbying escalation reads, in this context, less like confidence and more like contingency planning. Federal venue is worth fighting for in court. But if the preemption argument eventually produces a circuit split — or if New York survives long enough to develop its own evidentiary record — Congress becomes relevant. Lobbying now means Kalshi is positioned if the legal route narrows.

The Polymarket soldier case adds a different pressure point. That defendant's opposition to a CFTC court filing in a criminal proceeding is a reminder that the Commission is attempting to extend its jurisdictional reach across multiple simultaneous proceedings, not all of which it controls. In the Van Dyke matter, courts have already limited CFTC's amicus role. A similar pattern in the military insider case would further establish that CFTC enforcement authority in prediction market contexts is not self-executing — it requires courts to affirmatively grant the Commission a place in proceedings it did not initiate.

The standard that governs is whether CFTC's jurisdictional claims under 7 U.S.C. § 7a-3 are broad enough to preempt state authority and broad enough to permit intervention in federal criminal proceedings where the predicate conduct involves designated contract markets. Those are two distinct legal questions that happen to be moving through the courts simultaneously, and the answers need not be consistent with each other.